Concepedia

Julie L. Wilsbacher

JL

Statistics

Publications

26

Citations

3.3K

H-Index

21

Active since

1998

Affiliations

The University of Texas Southwestern Medical Center(Current)

Abbott Fund

AbbVie (United States)

Harvard University

Abbott (United States)

Julie L. Wilsbacher is an author at The University of Texas Southwestern Medical Center specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

1998–2018

26

Publications

26

Phosphorylation of the MAP Kinase ERK2 Promotes Its Homodimerization and Nuclear Translocation

Andrei Khokhlatchev, Bertram Canagarajah, Julie L. Wilsbacher et al. · Cell · 1998 · 677 citations · Full text

, , +10

WNK1, a Novel Mammalian Serine/Threonine Protein Kinase Lacking the Catalytic Lysine in Subdomain II

Bing-e Xu, Jessie M. English, Julie L. Wilsbacher et al. · Journal of Biological Chemistry · 2000 · 527 citations · Full text

Mechanistic Dissection of PARP1 Trapping and the Impact on <i>In Vivo</i> Tolerability and Efficacy of PARP Inhibitors

Todd A. Hopkins, Yan Shi, Luis E. Rodrı́guez et al. · Molecular Cancer Research · 2015 · 257 citations

PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow

Todd A. Hopkins, William B. Ainsworth, Paul A. Ellis et al. · Molecular Cancer Research · 2018 · 250 citations

Vav GEFs are required for β2 integrin-dependent functions of neutrophils

M. Angelica Martinez Gakidis, Xavier Culleré, Timothy S. Olson et al. · The Journal of Cell Biology · 2004 · 221 citations · Full text

, , +14

1–5 of 26